IP Library Granted Patent US 7,183,119
Granted Patent B2
US 7,183,119 · App. 10/989,072 · Granted Feb 27, 2007

Method for sensitive detection of multiple biological analytes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,183,119
App. No.
10/989,072
Granted
Feb 27, 2007
Kind
B2
Abstract

The present invention relates to a method of detecting biological analytes comprising suspending a target analyte in a suspending solution containing polymeric particles marked with a probe, wherein the probe has an affinity for said target analyte; adding recognition unit-peroxidase conjugate marker to the suspending solution; forming a complex of the target analyte, the polymeric particles marked with a probe, and the recognition unit-peroxidase conjugate marker; contacting a gelatin surface with the suspending solution; adding developer to the suspending solution in contact with the gelatin surface in the presence of phenol to attach the complex to the gelatin surface; washing the gelatin surface; and detecting the complex attached to the gelatin surface.

Claims (59)

1. A method of detecting biological analytes comprising:

suspending a target analyte in a suspending solution containing polymeric particles with an attached probe, wherein said probe has specific affinity for said target analyte;

adding at least one recognition unit-peroxidase conjugate marker to said suspending solution, wherein said recognition unit associates with said target analyte;

forming a complex of said target analyte, said polymeric particles with an attached probe, said recognition unit-peroxidase conjugate marker;

contacting a gelatin surface with said suspending solution;

adding developer to said suspending solution in contact with said gelatin surface in the presence of phenol to attach said complex to said gelatin surface;

washing said gelatin surface; and

detecting said complex attached to said gelatin surface.

2. The method of claim 1 wherein said target analyte is a protein.

3. The method of claim 1 wherein said target analyte is bacteria.

4. The method of claim 1 wherein said suspending solution is an aqueous solution.

5. The method of claim 4 wherein said suspending solution is buffered.

6. The method of claim 1 wherein said suspending solution further comprises phenol.

7. The method of claim 1 wherein said polymeric particles are organic.

8. The method of claim 1 wherein said polymeric particles are inorganic.

9. The method of claim 1 wherein said polymeric particles have a distinct color, shape or size.

10. The method of claim 9 wherein said shape is curvilinear, spherical, donut shaped, elliptical, rectangular, cubic, or rod.

11. The method of claim 9 wherein said color is derived from mixing three dyes representing the primary colors R, G, B to create distinct “color addresses.”

12. The method of claim 11 wherein each of said distinct “color addresses” corresponds to a specific bioactive probe.

13. The method of claim 9 wherein said color is derived by covalently coupling one or more dyes to the surface of said polymeric particles.

14. The method of claim 9 wherein said color is derived from micro-encapsulated colorants and pigments incorporated into said polymeric particles.

15. The method of claim 1 wherein said polymeric particles are polystyrene, poly(methyl methacrylate) and poly(butyl acrylate).

16. The method of claim 1 wherein said polymeric particles have a mean diameter of from 1 to 100 microns.

17. The method of claim 1 wherein said polymeric particles have a mean diameter of from 2 to 30 microns.

18. The method of claim 1 wherein said polymeric particles have a mean diameter of front 3 to 20 microns.

19. The method of claim 1 wherein said polymeric particles are monodisperse wherein the coefficient of the particle size distribution (i.e. the standard deviation as a percentage of the mean) will be less than 20%.

20. The method of claim 1 wherein said polymeric particles are a plurality of particles types, wherein each type of particle is distinguishable from each other type of particle.

21. The method of claim 1 wherein said probe is a protein capture agent.

22. The method of claim 1 wherein said probe is an antibody.

23. The method of claim 1 wherein said probe has an affinity binding constant to said target analyte of greater than 10 6 M −1 .

24. The method of claim 1 wherein said recognition unit is an antibody.

25. The method of claim 1 wherein said recognition unit has an affinity binding constant to the target analyte of no less than 10 6 M −1 .

26. The method of claim 1 wherein said recognition unit is the same as said probe.

27. The method of claim 1 wherein said recognition unit is a nucleic acid.

28. The method of claim 1 wherein said peroxidase is connected to the recognition unit covalently.

29. The method of claim 1 wherein said peroxidase is connected to the recognition unit non-covalently.

30. The method of claim 1 wherein said peroxidase is horseradish peroxidase (HRP).

31. The method of claim 1 wherein said gelatin is coated onto a support.

32. The method of claim 31 wherein said support is organic, inorganic or biological.

33. The method of claim 31 wherein said support is glass, quartz, plastics, metals, semiconductors, a porous membrane.

34. The method of claim 1 wherein said gelatin further comprises hardener.

35. The method of claim 1 wherein said gelatin has a laydown of from 0.2 to 100 grams per square meter.

36. The method of claim 1 wherein said gelatin has a laydown of from 10 to 50 grams per square meter.

37. The method of claim 1 wherein said developer contains hydrogen peroxide.

38. The method of claim 1 wherein the concentration of said hydrogen peroxide in said developer is from 0.01% (w/v) to 10% (w/v).

39. The method of claim 1 wherein said developer is aqueous.

40. The method of claim 1 wherein said developer is buffered.

41. The method of claim 1 wherein said developer further comprises phenol.

42. The method of claim 1 wherein said phenol is added prior to or simultaneously with said developer.

43. The method of claim 1 wherein said phenol is represented by the following general formula:

where R1, R2, R3, R4, R5 are independently a hydrogen, a substituted or unsubstituted linear or branched alkyl group of 1 to 10 carbon atoms, a substituted or unsubstituted aryl group of 6to 14 carbon atoms, a substituted or unsubstituted cycloalkyl group of 5 to 14 carbon atoms, a substituted or unsubstituted heterocyclic group, a solubilizing group, or a halogen atom of fluoride, chloride, bromide, iodide.

44. The method of claim 43 wherein at least one of R1, R2, R3, R4, R5 is or contains a solubilizing substituent that is generally negatively charged.

45. The method of claim 1 wherein said phenol is represented by at least one of the following structures:

46. The method of claim 1 wherein said washing is aqueous.

47. The method of claim 1 wherein said detecting is visual inspecting.

48. The method of claim 47 wherein said visual inspecting utilizes a microscope.

49. The method of claim 1 wherein said detecting is automatic imaging.

50. The method of claim 1 wherein said detecting is dark field illumination epi-illumination, phase-contrast microscopy, differential interference contrast microscopy (DIC), polarization microscopy, multi-spectral or hyper-spectral microscopy.

51. The method of claim 1 wherein said detecting is full-frame image capture.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Oct 14, 2022
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL, LLC; QUANTUM MEDICAL IMAGING, L.L.C.; QUANTUM MEDICAL HOLDINGS, LLC; TROPHY DENTAL INC.
Reel/Frame 061681/0380 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (SECOND LIEN) Recorded Mar 13, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.
Reel/Frame 027851/0812 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 12, 2011
From: CARESTREAM HEALTH, INC.; CARESTREAM DENTAL, LLC; QUANTUM MEDICAL IMAGING, L.L.C.; QUANTUM MEDICAL HOLDINGS, LLC; TROPHY DENTAL INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 026269/0411 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (FIRST LIEN) Recorded Apr 4, 2011
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: CARESTREAM HEALTH, INC.
Reel/Frame 026069/0012 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2008
From: EASTMAN KODAK COMPANY
To: CARESTREAM HEALTH, INC.
Reel/Frame 020741/0126 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2008
From: EASTMAN KODAK COMPANY
To: CARESTREAM HEALTH, INC.
Reel/Frame 020756/0500 →
FIRST LIEN OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 27, 2007
From: CARESTREAM HEALTH, INC.
To: CREDIT SUISSE, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 019649/0454 →
SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEME Recorded Jul 27, 2007
From: CARESTREAM HEALTH, INC.
To: CREDIT SUISSE, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 019773/0319 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2004
From: TIECHENG A. QIAO; KELLEY BRIAN J.
To: EASTMAN KODAK COMPANY
Reel/Frame 016009/0098 →